Now we determined that tumour heterogeneity by the sensitivity to trypsin showed significantly differential phenotypes of cell invasion and apoptosis, and CD39 was one of the important biomarkers for the identification of this tumour heterogeneity of colorectal cancer cells in vitro in our research system. The gene discussed is ENTPD1; the disease is neoplasm.